← Leaderboards
Brett Hurst
Utah State University
$2,029,807
Attributed
$2,029,807
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $775.1K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,029,807 · 1
By mechanism
N01$2,029,807 · 1
Top collaborators
No co-investigators on record.
Most similar at Utah State University
Same institution · by research overlap
- Donald Smee$3,274,857
- John Morrey$13,853,562
- Justin Julander$4,709,822
- John D Morrey$14,814,199
- Smee Donald$1,154,922
Others in their field
Other Emerging Leaders on “In Vitro Testing”
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,503,168
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,408,471
- Leonard Freedmand · Leidos Biomedical Research, Inc.$55,464,221
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$42,191,190
- Tony Moody · Duke University$34,777,314
- John Damon Chodera · Sloan-Kettering Inst Can Research$31,137,784
Research focus
In Vitro TestingCell LineContractsViralMaintenanceIn VitroAntimicrobialRespiratory VirusAdvanced DevelopmentAntiviral AgentsTherapeutic DevelopmentVirusVirus DevelopmentAnti-Viral AgentsMiddle East Respiratory Syndrome Coronavirus2019-NcovSars CoronavirusInfluenza TherapeuticRespiratory Syncytial VirusTherapeutic EvaluationScreeningParamyxovirusPathogenInfluenza
Grant awards (12)
Task B22: Comprehensive In Vitro Antiviral Screening Against BSL-4 Pathogens$540,000
N01 · FY2024 · AI · contact PI
Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2$206,532
N01 · FY2024 · AI · contact PI
Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses$22,948
N01 · FY2024 · AI · contact PI
Task B19: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2$5,000
N01 · FY2024 · AI · contact PI
Task B19: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses$572
N01 · FY2024 · AI · contact PI
TASK B19: IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY AGAINST RESPIRATORY VIRUSES$456,000
N01 · FY2023 · AI · contact PI
Task B09: Comprehensive Viral Screening Panel$40,252
N01 · FY2022 · AI · contact PI
Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, Including SARS-CoV-2$272,532
N01 · FY2021 · AI · contact PI
Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses$90,844
N01 · FY2021 · AI · contact PI
Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses$40,377
N01 · FY2021 · AI · contact PI
Task B03: In Vitro Assessments for Antimicrobial Activity Against Respiratory Viruses$319,275
N01 · FY2020 · AI · contact PI
Task B03: In Vitro Assessments for Antimicrobial Activity Against Respiratory Viruses$35,475
N01 · FY2020 · AI · contact PI